BARCLAYS PLC 13D and 13G filings for Kezar Life Sciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 12:24 pm Sale | 2024-09-30 | 13G | Kezar Life Sciences, Inc. KZR | BARCLAYS PLC | 0 0.000% | -382,878 (Position Closed) | Filing |
| 2024-02-14 6:44 pm Purchase | 2024-02-13 | 13G | Kezar Life Sciences, Inc. KZR | BARCLAYS PLC | 382,878 5.270% | 382,878 (New Position) | Filing |